Medical Director, Oncology Clinical Development, GSK; Attending Physician, Children's Hosp of
Potvrđena adresa e-pošte na
Discovery and clinical introduction of first-in-class imipridone ONC201
JE Allen, CLB Kline, VV Prabhu, J Wagner, J Ishizawa, N Madhukar, ...
Oncotarget 7 (45), 74380, 2016
Targeting TRAIL in the treatment of cancer: new developments
B Lim, JE Allen, VV Prabhu, MK Talekar, NK Finnberg, WS El-Deiry
Expert opinion on therapeutic targets 19 (9), 1171-1185, 2015
The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL).
S Maude, G Hucks, A Seif, M Talekar, D Teachey, D Baniewicz, ...
J Clin Oncol 35, 2017 (suppl; abstr 103), 2017
Efficacy of humanized CD19-targeted chimeric antigen receptor (CAR)-modified T cells in children and young adults with relapsed/refractory acute lymphoblastic leukemia
SL Maude, DM Barrett, SR Rheingold, R Aplenc, DT Teachey, C Callahan, ...
Blood 128 (22), 217, 2016
Understanding the differences between oncology patients and oncology health professionals concerning Spirituality/Religiosity: a cross-sectional study
MS Camargos, Mayara Goulart de RN, PD Paiva, Carlos Eduardo MD, ...
Medicine 94 (47), 2015
Genetic and pharmacological screens converge in identifying FLIP, BCL2, and IAP proteins as key regulators of sensitivity to the TRAIL-inducing anticancer agent ONC201/TIC10
JE Allen, VV Prabhu, M Talekar, APJ Van Den Heuvel, B Lim, DT Dicker, ...
Cancer research 75 (8), 1668-1674, 2015
DREAMM-6: Safety and tolerability of belantamab mafodotin in combination with bortezomib/dexamethasone in relapsed/refractory multiple myeloma (RRMM)
A Nooka, K Stockerl-Goldstein, H Quach, A Forbes, MV Mateos, A Khot, ...
ASCO Annual Meeting 2020, 2020
DREAMM-6: safety, tolerability and clinical activity of belantamab mafodotin (Belamaf) in combination with bortezomib/dexamethasone (BorDex) in relapsed/refractory multiple …
R Popat, A Nooka, K Stockerl-Goldstein, R Abonour, R Ramaekers, ...
Blood, The Journal of the American Society of Hematology 136 (Supplement 1 …, 2020
Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies
VV Prabhu, MK Talekar, AR Lulla, CLB Kline, L Zhou, J Hall, ...
Cell Cycle 17 (4), 468-478, 2018
A multicenter study of bacterial blood stream infections in pediatric allogeneic hematopoietic cell transplantation recipients: the role of acute gastrointestinal graft-versus …
P Satwani, JL Freedman, S Chaudhury, Z Jin, A Levinson, MD Foca, ...
Biology of blood and marrow transplantation 23 (4), 642-647, 2017
ONC201 Induces Cell Death in Pediatric non-Hodgkin's Lymphoma Cells
M Talekar, J Allen, D Dicker, W El-Deiry
Cell Cycle, 2015
Effect of chimeric antigen receptor-modified T (CAR-T) cells on responses in children with non-CNS extramedullary relapse of CD19+ acute lymphoblastic leukemia (ALL)
M Talekar, S Maude, G Hucks, L Motley, C Callahan, C White, ...
J Clin Oncol 35, 2017 (suppl; abstr 1050), 2017
Potassium changes associated with blood transfusion in pediatric patients
J Olson, M Talekar, M Sachdev, W Castellani, N De la Cruz, J Davis, ...
American journal of clinical pathology 139 (6), 800-805, 2013
A case of severe chlorite poisoning successfully treated with early administration of methylene blue, renal replacement therapy, and red blood cell transfusion: case report
A Gebhardtova, P Vavrinec, D Vavrincova-Yaghi, M Seelen, A Dobisova, ...
Medicine 93 (9), 2014
Immune reconstitution after hematopoietic stem cell transplantation
MK Talekar, T Olson
Hematopoietic stem cell transplantation for the pediatric hematologist …, 2018
DREAMM-7: a phase III study of the efficacy and safety of belantamab mafodotin (belamaf) with bortezomib, and dexamethasone (B-Vd) in patients with relapsed/refractory multiple …
RM Rifkin, K Boyd, S Grosicki, K Kim, F Di Raimondo, MA Dimopoulos, ...
Blood 136, 53-54, 2020
DREAMM 4: a phase I/II single-arm open-label study to explore safety and clinical activity of belantamab mafodotin (GSK2857916) administered in combination with pembrolizumab …
S Trudel, A Nooka, D Fecteau, M Talekar, RC Jewell, D Williams, J Evans, ...
Annals of Oncology 30, v447, 2019
Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer
W Zhang, R Jiang, J Hou, B Sun
Medicine 94 (12), 2015
Congenital self-healing reticulohistiocytosis
YH Lee, MK Talekar, CG Chung, MD Bell, AL Zaenglein
The Journal of Clinical and Aesthetic Dermatology 7 (2), 49, 2014
Phase I/II, Open-label, 2-Arm Study to Evaluate Safety, Tolerability and Clinical Activity of GSK2857916 in Combination with 2 Standard-of-Care (SoC) Regimens in Relapsed …
LJ Costa, H Quach, K Stockerl-Goldstein, B Augustson, G Ferron-Brady, ...
ASCO 2019, 2019
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20